Zhejiang Cancer Hospital
🇨🇳China
Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06741020
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Pharmacokinetic Study of Tranexamic Acid
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06728670
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）
- First Posted Date
- 2024-12-02
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 214
- Registration Number
- NCT06711432
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT06704698
- Locations
- 🇨🇳
Jiangling Wang, Hangzhou, Zhejiang, China
RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT06674096
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06650332
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 568
- Registration Number
- NCT06624878
GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-09-25
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 41
- Registration Number
- NCT06611826
CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: a Single-center, Randomized, Controlled Study
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-09-24
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 312
- Registration Number
- NCT06609551
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT06572319
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
© Copyright 2024. All Rights Reserved by MedPath